PADUANO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 240
EU - Europa 145
AS - Asia 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 400
Nazione #
US - Stati Uniti d'America 234
IT - Italia 89
GB - Regno Unito 20
SE - Svezia 16
DE - Germania 11
IN - India 8
CA - Canada 6
EU - Europa 3
RU - Federazione Russa 3
AT - Austria 2
FR - Francia 2
CN - Cina 1
IR - Iran 1
JP - Giappone 1
MY - Malesia 1
RO - Romania 1
UA - Ucraina 1
Totale 400
Città #
Chandler 66
Ashburn 20
London 19
Catanzaro 15
Chicago 14
Princeton 12
Lawrence 11
Isola di Capo Rizzuto 9
Hanover 8
Des Moines 7
Wilmington 7
Genova 5
Luni 5
Naples 4
Ottawa 4
Florence 3
Lurate Caccivio 3
Pune 3
Seattle 3
Treviso 3
Assago 2
Bathinda 2
Decollatura 2
Formia 2
Girifalco 2
Leawood 2
Paris 2
Peterborough 2
Pontedera 2
Rome 2
Troina 2
Vienna 2
Villongo 2
Acireale 1
Apo 1
Borås 1
Gaithersburg 1
Hyderabad 1
Kuala Lumpur 1
Moscow 1
Mumbai 1
Norwalk 1
Omsk 1
Parsberg 1
Phoenix 1
Pitesti 1
Rende 1
Saint Louis 1
San Mateo 1
Secaucus 1
Settingiano 1
Sezze 1
St Petersburg 1
Suzhou 1
Torre Del Lago 1
Vancouver 1
Washington 1
Yokohama 1
Totale 272
Nome #
Alternative splicing regulation in tumour cells of gene encoding the tyrosine phosphatase PTPRJ 40
Translational aspects of the modern genetics in head and neck cancers 39
The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells. 33
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome 33
A familial form of epidermolysis bullosa simplex associated with a pathogenic variant in krt5 31
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 30
7q35 microdeletion and 15q13.3 and xp22.33 microduplications in a patient with severe myoclonic epilepsy, microcephaly, dysmorphisms, severe psychomotor delay and intellectual disability 27
Germline Testing in a Cohort of Patients at High Risk of Hereditary Cancer Predisposition Syndromes: First Two-Year Results from South Italy 25
TCL1A interacts with TP63 and enhances the survival of Raji Burkitt lymphoma cell line. 24
A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells 23
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 23
A novel splice variant of the protein tyrosine phosphatase PTPRJ that encodes for a soluble protein involved in angiogenesis 20
Fhit delocalizes Annexin A4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel 16
null 14
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 13
PTPRJ agonist peptides effectively inhibit in vitro cancer cell proliferation and tube formation 13
Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328 12
Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro 12
The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90 9
Totale 437
Categoria #
all - tutte 4.203
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.203


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 4 1 0 2 0 1 3 4
2020/202150 1 0 2 2 0 11 23 0 1 5 5 0
2021/202257 0 0 0 17 2 4 0 7 10 8 8 1
2022/2023194 23 20 10 11 19 11 3 25 35 17 17 3
2023/2024121 17 14 9 9 11 41 2 8 3 2 5 0
Totale 437